학술논문
Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial)
Document Type
Article
Author
Source
In: BMJ Open . (BMJ Open, 6 April 2023, 13(4))
Subject
Language
English
ISSN
20446055